Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by barcodewhizon Jan 16, 2007 7:30pm
363 Views
Post# 12030608

great trading

great trading Great trading again today... higher high on big volume with a higher close. ALL GOOD There is clearly still substantial residual interest from the last financing... We had heard the book was over three times oversubscribed... and this stock is acting exactly like you would expect under those circumstances. An institutional trading colleague of mine told me the street is shopping for "tens of millions" of shares of Prometic right now. TALK ABOUT FEAST OR FAMINE EH ? I honestly cant recall better sentiment and trading than we are seeing right now... Alot of us longtimers have been saying there are two big keys to a turnaround in this company.... ---worldwide publicity and exposure ---large scale institutional buying ... and it would appear we are seeing both. I now expect us to breakout to the .75-$1.00 range short term. With ANY kind of resolution to the Catalyst / Melnyk / Hemosol situation... we'll go substantially higher. From what little I can glean from the Melnyk / Catalyst court situation... people are giving Melnyk close to zero chance of winning and preventing Catalyst from moving forward. THIS WOULD BE HUGE FOR PROMETIC.... Ironically, it would take us back to around 2004 when we were counting on a substantial license and value contribution from Hemosol. all good guys... Ironically, all the US Buzz seems to be around 1402... cant wait to get some tangible results and see how much companies will pay to license or buy it.
Bullboard Posts